Pluristem and the Alliance for Regenerative Medicine (ARM) Meet Congress on April 29, 2014; Evoke Pharma Initiates Phase 3 Clinical Trial of EVK-001

Print E-mail
By Staff and Wire Reports   
Tuesday, 22 April 2014 20:00
Below is a look at some of the headlines for companies that made news in the healthcare sector on April 22, 2014.
Read more...
 

Healthcare Review: Valeant, Novartis, Hospital Corp of America, Allergan, GW Pharmaceuticals

Print E-mail
By Staff and Wire Reports   
Tuesday, 22 April 2014 13:32
U.S. stocks rose on Tuesday, with both the S&P 500 and Nasdaq on track for a sixth straight day of gains as a number of bellwether companies reported strong results.
Read more...
 

Sagent Announces the Reintroduction of Adenosine Injection; Revance Announces Positive Results From the RT002

Print E-mail
By Staff and Wire Reports   
Monday, 21 April 2014 19:48
Below is a look at some of the headlines for companies that made news in the healthcare sector on April 21, 2014.
Read more...
 

Healthcare Review: Theravance, Sarepta Therapeutics, Prosensa Holding, AstraZeneca, Aastrom Biosciences

Print E-mail
By Staff and Wire Reports   
Monday, 21 April 2014 13:56
U.S. stocks were little changed on Monday as investors found little reason to push up prices after last week's rally, while the dollar reached a two-week high against the yen after Japan posted a record trade deficit.
Read more...
 

Galectin Announces First Patient Dosed in Phase 1 Trial of GR-MD-02; Targeted Medical Pharma Completes Middle East Distribution Agreement

Print E-mail
By Mary Davila   
Thursday, 17 April 2014 19:12
Below is a look at some of the headlines for companies that made news in the healthcare sector on April 17, 2014.
Read more...
 

Baxter Announces Primary Efficacy Endpoint for Phase 3 Trial of BAX 11; Cleveland Biolabs Successfuly Close of Phase 1 Study of CBL0102

Print E-mail
By Staff and Wire Reports   
Wednesday, 16 April 2014 18:19
Below is a look at some of the headlines for companies that made news in the healthcare sector on April 16, 2014.
Read more...
 

Healthcare Review: Verde Media Group, Apricus Biosciences, Zalicus, Quintiles Transnational, ConMed

Print E-mail
By Staff and Wire Reports   
Wednesday, 16 April 2014 12:37
U.S. stocks gained broadly on Wednesday, as rising hopes of economic stimulus from Asia helped boost investor confidence.
Read more...
 

Boston Scientific Reports FDA Approval for Heart Failure Devices; Teva Unveils Generic Lunesta Tablets in US

Print E-mail
By Staff and Wire Reports   
Tuesday, 15 April 2014 18:49
Below is a look at some of the headlines for companies that made news in the healthcare sector on April 15, 2014.
Read more...
 

Healthcare Review: Tekmira Pharmaceuticals, Herbalife, Halozyme, WebMD, Akorn

Print E-mail
By Staff and Wire Reports   
Tuesday, 15 April 2014 13:27
The Standard & Poor’s 500 Index erased losses as investors weighed corporate earnings, weaker-than-estimated economic data and tensions in Ukraine.
Read more...
 

Bristol-Myers Squibb Submits NDA to FDA for Fixed-Dose Combo Tablet; pSivida Announces PDUFA Date for ILUVIEN

Print E-mail
By Staff and Wire Reports   
Monday, 14 April 2014 19:58

Below is a look at some of the headlines for companies that made news in the healthcare sector on April 14, 2014.

Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 331
BioMedReports Pluristem and the Alliance for Regenerative Medicine (ARM) Meet Congress on April 29, 2014; Evoke Pharma Initi... http://t.co/CK7NfHB4Dc
15hreplyretweetfavorite
BioMedReports Healthcare Review: Valeant, Novartis, Hospital Corp of America, Allergan, GW Pharmaceuticals: U.S. stocks rose... http://t.co/h3Y9v19L5T
22hreplyretweetfavorite
BioMedReports Scientists discover a new way to enhance nerve growth following injury http://t.co/BMczOVIxOl
22hreplyretweetfavorite
navigation
Benzinga.com supporter Seeking Alpha Certified